13.07.2015 Views

in Albania - Instituti i Shendetit Publik

in Albania - Instituti i Shendetit Publik

in Albania - Instituti i Shendetit Publik

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

INTERNATIONAL PUBLIC HEALTH CONFERENCE IN TIRANA, ALBANIAThe treatment response <strong>in</strong> metastatic pancreaticcancer patientsBledi Kreka 1 , Dhurata Tarifa 1 , Manika Kreka 2 , Floreta Kurti 2 ,Gentiana Qirjako 3,41Oncology Service, University Hospital Center Mother Teresa , Tirana, <strong>Albania</strong>;2Faculty of Technical Medical Sciences, University of Medic<strong>in</strong>e, Tirana, <strong>Albania</strong>;3Faculty of Public Health, University of Medic<strong>in</strong>e, Tirana, <strong>Albania</strong>;4Institute of Public Health, Tirana, <strong>Albania</strong>.Aim: Treatment of pancreatic cancer rema<strong>in</strong>s ahuge challenge <strong>in</strong> Oncology. Chemotherapy is thema<strong>in</strong> and the only treatment <strong>in</strong> many cases, butespecially <strong>in</strong> the metastatic cancer of pancreas. Theaim of our study was to assess the role of patientperformance status (PS) <strong>in</strong> the understand<strong>in</strong>g thesuccess of treatment of progressed pancreaticcancer disease.Methods: There were 50 patients treated dur<strong>in</strong>g a3-year period (2010-1012) at the ChemotherapyUnit, Service of Oncology, at the public hospital<strong>in</strong> Tirana. All the patients were diagnosed withmetastatic cancer s<strong>in</strong>ce <strong>in</strong>itiation or they had relapseafter surgery. We did an evaluation for theperformance status accord<strong>in</strong>g to ECOG. Thepatients were divided <strong>in</strong>to two groups (each with25 patients): one group for <strong>in</strong>terval PS: 0-1 and thesecond group for the PS <strong>in</strong>terval: 2-3). The treatmentwas based on use of 5 Fu, every 21-28 days. Theevaluation was done after the first three cycles. Therewere excluded patients with very low performancestatus (those who could not use treatment); patientswith organ dysfunction; or patients above 70 years ofage.Results: In the first group, the patients had 90 cyclesof treatment, whereas <strong>in</strong> the second group there were130 cycles of treatment. In the first group, the partialresponse was achieved <strong>in</strong> 8 patients, whereas <strong>in</strong> thesecond group it was achieved <strong>in</strong> one patient only(P=0.03).Conclusion:The evaluation of performance status isan important parameter <strong>in</strong> the decision for treatmentof veryprogressed metastatic cancer. Our f<strong>in</strong>d<strong>in</strong>gs arecompatible with previous reports on this matter.Keywords: cancer patients, pancreatic cancer, performance status.ALBANIAN MEDICAL JOURNAL SUPPLEMENT45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!